BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12878607)

  • 1. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
    Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
    J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.
    Garcia J; de Gunzburg J; Eychène A; Gisselbrecht S; Porteu F
    Mol Cell Biol; 2001 Apr; 21(8):2659-70. PubMed ID: 11283246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1.
    Schmitt JM; Stork PJ
    Mol Cell Biol; 2001 Jun; 21(11):3671-83. PubMed ID: 11340161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic-GMP-dependent protein kinase inhibits the Ras/Mitogen-activated protein kinase pathway.
    Suhasini M; Li H; Lohmann SM; Boss GR; Pilz RB
    Mol Cell Biol; 1998 Dec; 18(12):6983-94. PubMed ID: 9819386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes.
    Buscà R; Abbe P; Mantoux F; Aberdam E; Peyssonnaux C; Eychène A; Ortonne JP; Ballotti R
    EMBO J; 2000 Jun; 19(12):2900-10. PubMed ID: 10856235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-Ras signaling and K-Ras signaling are differentially dependent on endocytosis.
    Roy S; Wyse B; Hancock JF
    Mol Cell Biol; 2002 Jul; 22(14):5128-40. PubMed ID: 12077341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Raf-1 during experimental gastric ulcer healing is Ras-mediated and protein kinase C-independent.
    Pai R; Jones MK; Tomikawa M; Tarnawski AS
    Am J Pathol; 1999 Nov; 155(5):1759-66. PubMed ID: 10550332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf.
    Bergo MO; Gavino BJ; Hong C; Beigneux AP; McMahon M; Casey PJ; Young SG
    J Clin Invest; 2004 Feb; 113(4):539-50. PubMed ID: 14966563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism.
    Ramos JW; Hughes PE; Renshaw MW; Schwartz MA; Formstecher E; Chneiweiss H; Ginsberg MH
    Mol Biol Cell; 2000 Sep; 11(9):2863-72. PubMed ID: 10982386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling.
    Agazie YM; Hayman MJ
    Mol Cell Biol; 2003 Nov; 23(21):7875-86. PubMed ID: 14560030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-directed expression of Q227L-G alpha(s) inhibits growth of established tumors of later-stage human breast cancer cells in athymic mice.
    Santore TA; Chen Y; Smit MJ; Iyengar R
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1671-6. PubMed ID: 11805301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin stimulates primary beta-cell proliferation via Raf-1 kinase.
    Beith JL; Alejandro EU; Johnson JD
    Endocrinology; 2008 May; 149(5):2251-60. PubMed ID: 18202127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2.
    Yang L; Berk SC; Rohrer SP; Mosley RT; Guo L; Underwood DJ; Arison BH; Birzin ET; Hayes EC; Mitra SW; Parmar RM; Cheng K; Wu TJ; Butler BS; Foor F; Pasternak A; Pan Y; Silva M; Freidinger RM; Smith RG; Chapman K; Schaeffer JM; Patchett AA
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10836-41. PubMed ID: 9724791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.
    Weidner P; Saar D; Söhn M; Schroeder T; Yu Y; Zöllner FG; Ponelies N; Zhou X; Zwicky A; Rohrbacher FN; Pattabiraman VR; Tanriver M; Bauer A; Ahmed H; Ametamey SM; Riffel P; Seger R; Bode JW; Wade RC; Ebert MPA; Kragelund BB; Burgermeister E
    Cancer Lett; 2024 Apr; 588():216783. PubMed ID: 38462034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bacterial toxin that cleaves Ras oncoprotein.
    Biancucci M; Satchell KJ
    Oncotarget; 2015 Aug; 6(22):18742-3. PubMed ID: 26300052
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered Protein Interactions of the Endogenous Interactome of PTPIP51 towards MAPK Signaling.
    Brobeil A; Chehab R; Dietel E; Gattenlöhner S; Wimmer M
    Biomolecules; 2017 Jul; 7(3):. PubMed ID: 28754031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic Control of Metabolism.
    Pavlova NN; Thompson CB
    Cold Spring Harb Perspect Med; 2024 Apr; ():. PubMed ID: 38565265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide attenuates intestinal barrier damage by maintaining basal autophagy in Caco2 cells.
    Liu X; Zhou Y; Zhang Y; Cui X; Yang D; Li Y
    Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38577927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin and Somatostatin Receptors in Tumour Biology.
    Kumar U
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Interactions of Mouse Melanocortin Receptor Accessory Proteins with Somatostatin Receptors.
    Wang M; Xu J; Lei XW; Zhang C; Liu SY; Jin LN; Zhang C
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.